These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. MitoTEMPO provides an antiarrhythmic effect in aged-rats through attenuation of mitochondrial reactive oxygen species. Olgar Y; Billur D; Tuncay E; Turan B Exp Gerontol; 2020 Jul; 136():110961. PubMed ID: 32325093 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy. Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173 [TBL] [Abstract][Full Text] [Related]
7. Liraglutide provides cardioprotection through the recovery of mitochondrial dysfunction and oxidative stress in aging hearts. Durak A; Turan B J Physiol Biochem; 2023 May; 79(2):297-311. PubMed ID: 36515811 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure. Dey S; DeMazumder D; Sidor A; Foster DB; O'Rourke B Circ Res; 2018 Jul; 123(3):356-371. PubMed ID: 29898892 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome. Fujii Y; Matsumura H; Yamazaki S; Shirasu A; Nakakura H; Ogihara T; Ashida A PLoS One; 2020; 15(1):e0227414. PubMed ID: 31905213 [TBL] [Abstract][Full Text] [Related]
10. MitoTEMPO Prevents Oxalate Induced Injury in NRK-52E Cells via Inhibiting Mitochondrial Dysfunction and Modulating Oxidative Stress. Zhang J; Wang Q; Xu C; Lu Y; Hu H; Qin B; Wang Y; He D; Li C; Yu X; Wang S; Liu J Oxid Med Cell Longev; 2017; 2017():7528090. PubMed ID: 28116040 [TBL] [Abstract][Full Text] [Related]
16. Effects of Aging on Cardiac Oxidative Stress and Transcriptional Changes in Pathways of Reactive Oxygen Species Generation and Clearance. Rizvi F; Preston CC; Emelyanova L; Yousufuddin M; Viqar M; Dakwar O; Ross GR; Faustino RS; Holmuhamedov EL; Jahangir A J Am Heart Assoc; 2021 Aug; 10(16):e019948. PubMed ID: 34369184 [TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeted antioxidant therapy with MitoQ ameliorates aortic stiffening in old mice. Gioscia-Ryan RA; Battson ML; Cuevas LM; Eng JS; Murphy MP; Seals DR J Appl Physiol (1985); 2018 May; 124(5):1194-1202. PubMed ID: 29074712 [TBL] [Abstract][Full Text] [Related]
18. Sinapine, but not sinapic acid, counteracts mitochondrial oxidative stress in cardiomyocytes. Boulghobra D; Grillet PE; Laguerre M; Tenon M; Fauconnier J; Fança-Berthon P; Reboul C; Cazorla O Redox Biol; 2020 Jul; 34():101554. PubMed ID: 32464499 [TBL] [Abstract][Full Text] [Related]
19. Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle. Sakellariou GK; Pearson T; Lightfoot AP; Nye GA; Wells N; Giakoumaki II; Griffiths RD; McArdle A; Jackson MJ FASEB J; 2016 Nov; 30(11):3771-3785. PubMed ID: 27550965 [TBL] [Abstract][Full Text] [Related]
20. Ameliorative Effect of Epigallocatechin Gallate on Cardiac Hypertrophy and Fibrosis in Aged Rats. Muhammed I; Sankar S; Govindaraj S J Cardiovasc Pharmacol; 2018 Feb; 71(2):65-75. PubMed ID: 29419571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]